Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Beat Estimates
Werte in diesem Artikel
Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.50 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 5.85%. A quarter ago, it was expected that this company would post earnings of $1.77 per share when it actually produced earnings of $2.21, delivering a surprise of 24.86%.Over the last four quarters, the company has surpassed consensus EPS estimates four times.Intuitive Surgical, which belongs to the Zacks Medical - Instruments industry, posted revenues of $2.25 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.27%. This compares to year-ago revenues of $1.89 billion. The company has topped consensus revenue estimates three times over the last four quarters.The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.Intuitive Surgical shares have lost about 10.3% since the beginning of the year versus the S&P 500's decline of -12.3%.What's Next for Intuitive Surgical?While Intuitive Surgical has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.Ahead of this earnings release, the estimate revisions trend for Intuitive Surgical: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $1.96 on $2.33 billion in revenues for the coming quarter and $7.97 on $9.56 billion in revenues for the current fiscal year.Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Instruments is currently in the top 30% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.Another stock from the same industry, Orthofix (OFIX), has yet to report results for the quarter ended March 2025. The results are expected to be released on May 6.This medical device maker is expected to post quarterly loss of $0.17 per share in its upcoming report, which represents a year-over-year change of +63%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.Orthofix's revenues are expected to be $190.1 million, up 0.8% from the year-ago quarter.Should You Invest in Intuitive Surgical, Inc. (ISRG)?Before you invest in Intuitive Surgical, Inc. (ISRG), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.Zacks Investment Research has been committed to providing investors with tools and independent research since 1978. For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% per year. (These returns cover a period from January 1, 1988 through May 6, 2024.)Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis Report ORTHOFIX MEDICAL INC. (OFIX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Intuitive Surgical und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Intuitive Surgical
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Intuitive Surgical
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Intuitive Surgical Inc
Analysen zu Intuitive Surgical Inc
Datum | Rating | Analyst | |
---|---|---|---|
19.07.2019 | Intuitive Surgical Buy | Canaccord Adams | |
22.04.2019 | Intuitive Surgical Buy | Canaccord Adams | |
02.04.2019 | Intuitive Surgical Buy | Deutsche Bank AG | |
19.10.2018 | Intuitive Surgical Buy | Canaccord Adams | |
18.04.2018 | Intuitive Surgical Buy | Canaccord Adams |
Datum | Rating | Analyst | |
---|---|---|---|
19.07.2019 | Intuitive Surgical Buy | Canaccord Adams | |
22.04.2019 | Intuitive Surgical Buy | Canaccord Adams | |
02.04.2019 | Intuitive Surgical Buy | Deutsche Bank AG | |
19.10.2018 | Intuitive Surgical Buy | Canaccord Adams | |
18.04.2018 | Intuitive Surgical Buy | Canaccord Adams |
Datum | Rating | Analyst | |
---|---|---|---|
26.01.2018 | Intuitive Surgical Hold | Canaccord Adams | |
18.07.2017 | Intuitive Surgical Sector Perform | RBC Capital Markets | |
30.06.2017 | Intuitive Surgical Neutral | Cantor Fitzgerald | |
30.05.2017 | Intuitive Surgical Hold | Canaccord Adams | |
17.04.2017 | Intuitive Surgical Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
23.01.2015 | Intuitive Surgical Sell | CRT Capital | |
22.10.2014 | Intuitive Surgical Sell | CRT Capital | |
09.01.2009 | Intuitive Surgical Downgrade | Brean Murray, Carret & Co., LLC | |
26.08.2005 | Update Intuitive Surgical Inc. : Underperform | Jefferies & Co |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Intuitive Surgical Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen